NEWS & EVENTS 
SPECIALTY CARE
Type 2 diabetes is one of the most common, costly, and disabling diseases in the world. Approximately one million patients in Michigan have type 2 diabetes and rates are up to 2x higher for Michiganders who are Black, Latino, or have a disability. At the same time, the implementation of guideline concordant diabetes care lags behind due to challenges with coverage, lack of resources, cost of medications, and lack of support and education. Primary care practices continue to combat staffing issues, lack of resources, and increasing administrative demands. Meanwhile coordination of care for diabetes is confounded by an increasingly-complex healthcare system.
The Michigan Collaborative for Type 2 Diabetes (MCT2D) was established in 2021 to accelerate a new way forward, through collaboration, innovation, and investment in quality, evidence based care for type 2 diabetes. MCT2D strives to remove barriers to guideline concordant care, support participating practices, and keep patients central to quality improvement work.
Mission
MCT2D strives to prevent type 2 diabetes and its complications by fostering a collaborative community of clinicians and patients to accelerate the equitable implementation of evidence-based diabetes care for all patients in Michigan.
Vision
A world where Type 2 Diabetes is no longer a progressive disease.
Health Equity Vision
We envision a Michigan where all individuals have equitable access to the best care for type 2 diabetes regardless of race, ethnicity, socio-economic status, insurance coverage, or geographic location. Our collaborative efforts will lead to reduced prevalence and complications of type 2 diabetes and improved quality of life for every patient.
LEARN MORE Quality Initiatives
Together, we work to accelerate the implementation of quality diabetes care, including three guiding initiatives
MORE ON QUALITY INITIATIVES
Care Collaboration
Bringing together primary care, endocrinology, nephrology, obesity medicine, pharmacy, dietetics, care management, and more to advance as a team.
Our Members
The Michigan Collaborative for Type 2 Diabetes is a coalition of over 1000 physicians, coming together from across 346 primary care, endocrinology, and nephrology practices, all of whom are represented by 28 physician organizations spanning the state.
MORE ON MEMBERSHIPHow MCT2D Supports Members
Nearly 100 free tools and resources, developed and curated by the MCT2D team.
Guides to coverage for CGM, GLP-1 RA and SGLT2i, patient education on low carb lifestyle, videos, interactive websites, one-page handouts, and more.
Know exactly what you need to do next using our administrative portal.
Monitor your practices’ and physicians’ participation in real-time and never miss a VBR deadline with auto-reminders and customized check lists. Requires Member Login - Ask PO Lead for Access
Get support, learn, and grow in community.
Monthly learning events with continuing education and VBR credit. Workgroups and networking for the entire diabetes care team. Crowdsourced knowledge like our dot phrase library and best practice database. One-on-one consultations with MCT2D experts.
A responsive team, ready to answer your questions.
Connect with the MCT2D coordinating center by email: ccteam@mct2d.org or learn more about us.
Meet the Program Directors
Lauren Oshman, MD, MPH
Program Director
Dr. Oshman is a family physician and clinical associate professor in the University of Michigan Department of Family Medicine. Prior to joining the University of Michigan in 2020, she practiced for five years in Concord, New Hampshire, then served as a residency faculty member and vice-chair for quality at NorthShore University Health System in Chicago.
Heidi L. Diez, PharmD, BCACP
Co-Director
Dr. Diez is a clinical pharmacist specialist and clinical associate professor in the University of Michigan College of Pharmacy. She graduated from the University of Michigan (UM) College of Pharmacy (2004) and completed a community practice residency at the University of Washington and Kelley Ross Pharmacy in Seattle, WA (2005).
OUR TEAM
NEWSLETTERS
News from the MCT2D Team
MCT2D September 2025 Newsletter
Last updated: Thursday, September 25, 2025
PO Monthly Digest September 2025
Last updated: Wednesday, July 23, 2025
Value Based Reimbursement
- The new value-based reimbursement year for primary care physicians begins on 9/1/2025.
- Physicians approved for VBR will be visible in the portal on 9/2/2025 based on the lists that the PO admin leads/primary contacts reviewed in July.
Meetings
- PO calls this month are on Monday, September 8th at 11am and Wednesday, September 10th at 2pm.
- The September learning community event will take place on Friday, September 26th, and will be led by Rina Hisamatsu, RDN, and be focused on low carbohydrate diets. Register here.
- Registration for the fall regional meetings (taking place Wednesday, October 22nd and Thursday, November 13th) will open in September.
Tools
- MCT2D has created a patient focused handout on urine albumin creatinine ratio screening. The tool is available here
- We are also finalizing a provider-focused uACR tool and will be sharing it within the next couple of weeks. Upon release, you will have the opportunity to review the tool right away and provide feedback on its utility, earning physician-level learning community credit for your input.
- The MCT2D endocrinology leads have been developing a suite of tools for patients who are on insulin, and we hope to have these available to the collaborative before the end of the month. We will notify clinical champions via email once these are available.
Other
- MCT2D has partnered with Advanced Health Technology Solutions (AHTS) to help support the health information exchange. Ed Worthington from AHTS will be reaching out to each PO to set up a meeting to understand your current data submission process and ACRS attribution.
- The MCT2D smartphone application is now available! If you haven’t downloaded it, please click this link for more information.
- MCT2D is working on updates to the MCT2D Admin Portal to make it more streamlined and user friendly based on feedback from users. We hope to launch a new version this fall.
New Resources: Urine-to-Creatinine Ratio Test (uACR) - Guides for Clinicians and Patients
Last updated: Friday, September 12, 2025
MCT2D is excited to announce the release of two new handouts focused on the urine albumin-to-creatinine ratio (uACR) test, a key measure for detecting early kidney damage in people living with type 2 diabetes.
Subscribe to the MCT2D Newsletter
Once per month we deliver news, updates, events, and more directly to you!
ccteam@mct2d.org
Support for The Michigan Collaborative for Type 2 Diabetes (MCT2D) is provided by Blue Cross Blue Shield of Michigan as part of the BCBSM Value Partnerships program.
Although Blue Cross Blue Shield of Michigan and MCT2D work collaboratively, the opinions, beliefs and viewpoints expressed by the author do not necessarily reflect the opinions, beliefs and viewpoints of BCBSM or any of its employees.